National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Chronic Myelogenous Leukemia Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 10/30/2009



General Information About Chronic Myelogenous Leukemia






Stages of Chronic Myelogenous Leukemia






Relapsed Chronic Myelogenous Leukemia






Treatment Option Overview






Treatment Options for Chronic Myelogenous Leukemia







To Learn More About Chronic Myelogenous Leukemia






Get More Information From NCI






Changes to This Summary (10/30/2009)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Questions about cancer?

1-800-4-CANCER
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to the Nation Finds Continued Declines in Cancer Rates
To Learn More About Chronic Myelogenous Leukemia

For more information from the National Cancer Institute about chronic myelogenous leukemia, see the following:

For general cancer information and other resources from the National Cancer Institute, see the following:

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov